Novel polymer micelles for targeted drug delivery in pancreatic cancer
Introducing novel polar polymer micelles designed for effective drug delivery in pancreatic ductal adenocarcinoma. These micelles penetrate the extracellular matrix, enhancing drug delivery to tumor cells and improving treatment efficacy.
Overview
Pancreatic ductal adenocarcinoma (PDAC) presents significant treatment challenges due to its dense extracellular matrix (ECM) that hinders effective drug delivery. This innovative solution involves the use of novel polymer micelles with a polar nature, specifically designed to penetrate this tough ECM barrier. By encapsulating drugs within these micelles, the solution ensures enhanced penetration into the tumor microenvironment, leading to increased drug delivery to cancer cells. This approach promises to overcome the limitations of current antibody drug conjugates, offering a new avenue for effective treatment of PDAC.
Technical specifications
- Polar micelles: Engineered to target the polar ECM of PDAC, optimizing penetration and drug release.
- Drug encapsulation: Micelles carry a precise concentration of chemotherapeutic drugs, releasing them upon reaching the tumor cells.
- In-silico validation: Extensive simulation (500ns) demonstrates stability, permeability, and cytoplasmic disintegration under acidic conditions.
- In-vitro study plans: Validation using PDAC cell lines such as AsAC-1, BxPC-3, CAPAN-1, and others to assess drug response dynamics and enhance specificity and sensitivity.
Technology readiness level
Currently at TRL 3, this technology has undergone successful in-silico validation and is poised for in-vitro studies to further validate its efficacy in real-world biological environments. This stage is crucial for understanding the interactions between the micelles and tumor cells and refining the delivery system for clinical applications.
About R.V. College of Engineering
RV College of Engineering (RVCE) is an autonomous, self‑financing engineering institution in Bengaluru, affiliated to Visvesvaraya Technological University and accredited NAAC A+. It connects to industry through an active Industry Institute Interaction Cell, 150+ MoUs, and co‑located, industry‑sponsored labs and Centers of Excellence that enable joint training, prototyping, and upskilling on campus. Proximity to Bengaluru’s technology cluster supports internships, capstone co‑supervision, and consultancy engagements throughout the year. Research here is supported by competitive national programs and industry, including DRDO/NRB, AICTE, and ISRO collaborations. An IP Coordination Cell, together with incubation resources and a student‑run Entrepreneurship Development Cell, assists with patenting, licensing, and venture formation.
delivered to your inbox.